US Patent 11286256 Bicyclic inhibitors of histone deacetylase
Patent 11286256 was granted and assigned to Alkermes (company) on March, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11286256 Bicyclic inhibitors of histone deacetylase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
